lymphoma: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
CD2_IMMUNOPROLIFERATIVE
Extra metadata
List of similar endpoints to
Malignant immunoproliferative diseases
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 123 | 59 | 64 |
| Unadjusted prevalence (%) | 0.05 | 0.04 | 0.06 |
| Mean age at first event (years) | 64.26 | 64.64 | 63.91 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | - | - | - | - |
| 15 years | - | - | - | - |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: CD2_IMMUNOPROLIFERATIVE – Malignant immunoproliferative diseases
GWS hits: 1
before Malignant immunoproliferative diseases
after Malignant immunoproliferative diseases
Loading survival analyses plot
Loading survival analyses table
